Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for MHTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2024 0.074M
March 31, 2024 0.091M
December 31, 2023 0.316M
September 30, 2023 0.432M
June 30, 2023 0.569M
March 31, 2023 0.694M
December 31, 2022 1.031M
September 30, 2022 1.364M
June 30, 2022 1.364M
March 31, 2022 2.889M
December 31, 2021 3.454M
September 30, 2021 3.486M
June 30, 2021 4.555M
March 31, 2021 7.08M
December 31, 2020 6.848M
September 30, 2020 4.024M
June 30, 2020 2.15M
March 31, 2020 1.577M
December 31, 2019 2.225M
September 30, 2019 3.175M
June 30, 2019 1.872M
March 31, 2019 2.402M
December 31, 2018 2.66M
September 30, 2018 6.247M
June 30, 2018 6.124M
Date Value
March 31, 2018 8.058M
December 31, 2017 10.85M
September 30, 2017 14.58M
June 30, 2017 15.28M
March 31, 2017 9.053M
December 31, 2016 7.635M
September 30, 2016 8.532M
June 30, 2016 9.514M
March 31, 2016 11.19M
December 31, 2015 12.87M
September 30, 2015 14.23M
June 30, 2015 16.03M
March 31, 2015 17.62M
December 31, 2014 3.633M
September 30, 2014 2.351M
June 30, 2014 2.932M
March 31, 2014 3.16M
December 31, 2013 1.861M
September 30, 2013 2.071M
June 30, 2013 2.487M
March 31, 2013 2.091M
December 31, 2012 1.853M
September 30, 2012 2.067M
June 30, 2012 2.205M
March 31, 2012 2.367M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. 121.66M
Exicure, Inc. 11.40M
Century Therapeutics, Inc. 287.01M
Absci Corp. 268.92M
Celularity, Inc. 302.90M